Lycopus Liquid
FDA Label NDC 60986-1030

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Marco Pharma International Llc. for the product Lycopus (NDC 60986-1030). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredients, purpose, otc - keep out of reach of children, dosage, warnings, dosage & administration, inactive ingredients, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredients

Bugleweed 1X HPUS

Sponge 1X HPUS

Stone Blossom 6X HPUS

Quinine 6X HPUS

Tribasic calcium phosphate 8X HPUS

Magnesium hydrogen phosphate 8X HPUS

The letters HPUS indicates that the components in this product are officially monographed in the Homeopathic Pharmacopoeia of United Sates.

Purpose

For thyroid conditions: hyperthyroid with palpitations.

Otc - Keep Out Of Reach Of Children

Keep out of reach of children.

Dosage

Adults take 5 drops on the tongue or in 1 tablespoon water 3 times daily, increasing by one drop daily until reaction level is reached. Maxixum amount: 20 drops three times daily. Children receive 1/2 or less of the adult amount.

Warnings

If pregnant or breast-feeding, consult a health professional before use.

Dosage & Administration

(Read Suggested Use Section)

Inactive Ingredients

Ethyl Alcohol (53% by vol.) and Water

Package Label.Principal Display Panel

Lycopus.jpg

* Please review the disclaimer below.